Try our Advanced Search for more refined results
Searching dockets in Novitium Pharma Llc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Brief - Answering Brief in Opposition
ANSWERING BRIEF in Opposition re 71 MOTION to Bifurcate MOTION to Stay , 58 MOTION to Bifurcate /Plaintiffs and Counter-Defendants Harmony Biosciences Management, Inc., Harmony Biosciences, LLC, Harmony Biosciences Holdings, Inc., and Novitium Pharma LLC's Motion to Bifurcate and MOTION to Stay Antitrust Counterclaims filed by AET Pharma US, Inc., Sandoz AG, Sandoz Inc..Reply Brief due date per Local Rules is 9/18/2026. (Gattuso, Dominick)
Bifurcate Stay
MOTION to Bifurcate , MOTION to Stay - filed by AET Pharma US, Inc., Sandoz AG, Sandoz Inc.. (Attachments: # 1 Certificate Pursuant to District of Delaware Local Rule 7.1.1, # 2 Text of Proposed Order)(Gattuso, Dominick)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.